Dr. Charles W Lynde
Claim this profileLynderm Research Inc.
Studies Eczema
Studies Atopic Dermatitis
12 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Charles W Lynde is currently running
Baricitinib
for Pediatric Hair Loss
This trial is testing baricitinib, a medication that may help treat severe hair loss. It targets children aged 6 to less than 18 years who have significant hair loss. The medication works by reducing the immune system's activity that causes hair loss.
Recruiting1 award Phase 35 criteria
Deucravacitinib
for Plaque Psoriasis
The purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of Deucravacitinib in pediatric participants aged 4 to \<18 years with moderate to severe plaque psoriasis. This study includes two cohorts; Cohort 1 (age 12 to \<18 years) and Cohort 2 (age 4 to \<12 years), with two parts; for each cohort. Part A will evaluate the drug levels of BMS-986165 to enable selection of 2 dose levels to be studied in Part B. Part B will assess the efficacy and safety of two dose levels in pediatric participants with moderate to severe plaque psoriasis. The 5-year long-term extension (LTE) period will observe the long-term safety and tolerability of deucravacitinib in pediatric participants with psoriasis who have completed Parts A or B of the study.
Recruiting1 award Phase 35 criteria
More about Charles W Lynde
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Charles W Lynde has experience with
- Baricitinib
- GSK1070806
- Deucravacitinib (BMS-986165)
- Lebrikizumab
- Mirikizumab
- LY3454738
Breakdown of trials Charles W Lynde has run
Eczema
Atopic Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles W Lynde specialize in?
Charles W Lynde focuses on Eczema and Atopic Dermatitis. In particular, much of their work with Eczema has involved treating patients, or patients who are undergoing treatment.
Is Charles W Lynde currently recruiting for clinical trials?
Yes, Charles W Lynde is currently recruiting for 5 clinical trials in Markham Ontario. If you're interested in participating, you should apply.
Are there any treatments that Charles W Lynde has studied deeply?
Yes, Charles W Lynde has studied treatments such as Baricitinib, GSK1070806, Deucravacitinib (BMS-986165).
What is the best way to schedule an appointment with Charles W Lynde?
Apply for one of the trials that Charles W Lynde is conducting.
What is the office address of Charles W Lynde?
The office of Charles W Lynde is located at: Lynderm Research Inc., Markham, Ontario L3P 1X3 Canada. This is the address for their practice at the Lynderm Research Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.